The aetiology and management of long-lasting sixth nerve palsy in ophthalmoplegic migraine

Cephalalgia

Volumn 27, Issue 3, 2007, Pages 275-278

  Manzouri, B ^a   Sainani, A ^a   Plant, G T ^a   Lee, J P ^a   Sloper, J ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

Botulinum toxin; Ophthalmoplegic migraine; Squint surgery

Indexed keywords

ANALGESIC AGENT; BOTULINUM TOXIN;

ABDUCENS NERVE PARALYSIS; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONVERGENT STRABISMUS; DIPLOPIA; EYE EXAMINATION; FEMALE; HUMAN; LUMBAR PUNCTURE; MALE; MIGRAINE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOPLEGIA; STRABISMUS; STRABISMUS SURGERY;

ABDUCENS NERVE DISEASES; ADULT; EYE DISEASES; FEMALE; HUMANS; MALE; MIGRAINE DISORDERS; OPHTHALMOPLEGIA; TREATMENT OUTCOME;

EID: 33847680639     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2006.01252.x     Document Type: Article

References (18)

1. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders. Cephalalgia 2004; 24 (Suppl. 1):1-151.
2. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 (Suppl. 7):1-96.
3. Walsh FB, Hoyt WF. Migraine. In: Cook DB, Miller N, Newman NM, editors. Clinical neuro-ophthalmology, 5th edn. Baltimore: Williams & Wilkins 1998:3681-7.
4. Doran M, Larner AJ. MRI findings in ophthalmoplegic migraine: nosological implications. J Neurol 2004; 251:100-1.
5. Mark AS, Casselman J, Brown D, Sanchez J, Kolsky M, Larsen TC 3rd et al. Ophthalmoplegic migraine: reversible enhancement and thickening of the cisternal segment of the oculomotor nerve on contrast-enhanced MR images. Am J Neuroradiol 1998; 19:1887-91.
6. van der Dussen DH, Bloem BR, Liauw L, Ferrari MD. Ophthalmoplegic migraine: migrainous or inflammatory? Cephalalgia 2004; 24:312-5.
7. Hansen SL, Borelli-Moller L, Strange P, Nielsen BM, Olesen J. Ophthalmoplegic migraine: diagnostic criteria, incidence of hospitalization and possible etiology. Acta Neurol Scand 1990; 81:54-60.
8. Celebisoy N, Sirin H, Gokcay F. Ophthalmoplegic migraine: two patients, one at middle age with abducens palsy. Cephalalgia 2004; 25:151-3.
9. De Renzi E, Nichelli P. Ophthalmoplegic migraine with persistent abducens nerve palsy. Eur Neurol 1977; 15:227-30.
10. Lee TG, Choi WS, Chung KC. Ophthalmoplegic migraine with reversible enhancement of intraparenchymal abducens nerve on MRI. Headache 2002; 42:140-1.
11. Verhagen WI, Prick MJ, van Dijk Azn R. Onset of ophthalmoplegic migraine with abducens palsy at middle age? Headache 2003; 43:798-800.
12. Holmes JM, Beck RW, Kip KE, Droste PJ, Leske DA. Botulinum toxin treatment versus conservative management in acute traumatic sixth nerve palsy. J AAPOS 2000; 4:145-9.
13. Lee JP, Harris S, Cohen J, Cooper K, MacEwen C, Jones S. Results of a prospective randomized trial of botulinum toxin therapy in acute unilateral sixth nerve palsy. J Paediatr Ophthalmol Strabismus 1994; 31:283-6.
14. White J, Dawson E, Lee JP. Botulinum toxin A: its use in the management of patients with binocular results. In: Spiritus M, editor. 25th Meeting of the European Strabismological Association. Lisse: Aeolus Press 1999:79-83.
15. Asbury AK, Aldredge H, Hershberg R, Fisher CM. Oculomotor palsy in diabetes mellitus: a clinico-pathological study. Brain 1970; 93:555-66.
16. Etminan M, Takkouche B, Isorna F, Samii A. Risk of ischaemic stroke in people with migraine: systemic review and meta-analysis of observational studies. BMJ 2005; 330:63.
17. Eisenkraft B, Orlando Ortiz A. Image evaluation of cranial nerves 3, 4 and 6. Semin Ultrasound CT MR 2001; 22:488-501.
18. Comer R, Dawson E, Plant G, Acheson J, Lee J. Causes and outcomes for patients presenting with diplopia to an eye casualty department. Eye (in press).